506365 STARSOURCE

Starsource Multitrade Share Price

 

 

Start SIP in STARSOURCE

Start SIP

Performance

  • Low
  • ₹135
  • High
  • ₹146
  • 52 Week Low
  • ₹63
  • 52 Week High
  • ₹153
  • Open Price₹135
  • Previous Close₹142
  • Volume21
  • 50 DMA₹123.20
  • 100 DMA₹121.45
  • 200 DMA₹116.91

Investment Returns

  • Over 1 Month + 17.92%
  • Over 3 Month + 16.65%
  • Over 6 Month + 18.5%
  • Over 1 Year + 55.88%

Smart Investing Starts Here Start SIP with Starsource Multitrade for Steady Growth!

Invest Now

Starsource Multitrade Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.8
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 22
  • P/B Ratio
  • 15.2
  • Average True Range
  • 14.4
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 5.58
  • RSI
  • 63.24
  • MFI
  • 88.64

Starsource Multitrade Financials

Starsource Multitrade Technicals

EMA & SMA

Current Price
₹145.75
+ 4 (2.82%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹129.82
  • 50 Day
  • ₹123.20
  • 100 Day
  • ₹121.45
  • 200 Day
  • ₹116.91

Resistance and Support

142.07 Pivot Speed
  • R3 160.48
  • R2 153.12
  • R1 149.43
  • S1 138.38
  • S2 131.02
  • S3 127.33

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Starsource Multitrade Ltd has an operating revenue of Rs. 1.22 Cr. on a trailing 12-month basis. An annual revenue de-growth of -66% needs improvement, Pre-tax margin of 0% needs improvement, ROE of 2% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It has recently broken out of a base in its weekly chart and is trading around -6% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 86 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Starsource Multitrade Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-22 Others Inter-alia, to consider 1. Request letter dated 11/08/2025 received for reclassification of the status by Ms. Shanta Somani from "Promoter Group Shareholder" to "Public Shareholder"
2025-08-12 Quarterly Results & A.G.M.
2025-07-31 Others Inter-alia 1. To consider and accept resignation of existing statutory auditors. 2. To appoint fresh statutory auditors to fill the casual vacancy.
2025-05-29 Audited Results

Starsource Multitrade F&O

Starsource Multitrade Shareholding Pattern

27.89%
0.17%
65.66%
6.28%

About Starsource Multitrade

  • NSE Symbol
  • STARSOURCE
  • BSE Symbol
  • 506365
  • Managing Director & CEO
  • Mr. Ruchit Mehta
  • ISIN
  • INE320M01019

Similar Stocks to Starsource Multitrade

Starsource Multitrade FAQs

Starsource Multitrade share price is ₹145 As on 18 January, 2026 | 04:12

The Market Cap of Starsource Multitrade is ₹21.9 Cr As on 18 January, 2026 | 04:12

The P/E ratio of Starsource Multitrade is -1.8 As on 18 January, 2026 | 04:12

The PB ratio of Starsource Multitrade is 15.2 As on 18 January, 2026 | 04:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23